这globalgenomics in cancer care market根据Polaris市场研究发布的一份新报告，预计将在2019年至2025年以17.7％的复合年增长率达到146亿美元。乐动体育软件最新版这报告'癌症护理市场的基因组学份额，规模，趋势和行业分析报告，产品类型（耗材，仪器，服务）;通过技术，通过申请;结束使用;按地区：分部预测，2019年 - 2025'提供关于当前市场情景和未来前景的见解。
2018年，通过产品类型，仪器分部在收入方面占据最大的市场份额，并在市场上占据主要份额。地区，北美占全球市场的主要份额。
该市场主要推动全球癌症患者的患病率，以及对诊断的不断增长的需求加上成本效益和技术先进技术的可用性。此外，对个性化药物的意识和越来越偏好也在影响市场增长。此外，生物技术和制药公司的研究和发展持续投资也会推动市场增长。
Product segment is further sub-segmented into consumables and reagents, instruments, and services. Instruments market holds the major share in the market owning to the rapid technological advancements, and continuous efforts by the manufacturers for providing digitalization in the instruments for its easy use. While consumables and reagents hold second largest position for market followed by the service sub segment.
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：
//m.ptlymt.com/industry-analysis/genomics-in-cancer-care-market
Based on technology, the market is segmented as genome sequencing, PCR, microarray nucleic acid extraction and purification. Genome sequencing holds the major market share in 2017, and would continue to experience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results, and rising awareness for its use in cancer diagnosis. Moreover, advantages like growing demand for cost-effective technologies, and flexibility in this technique would also influence the growth of genome sequencing market.
On the basis of application, the market is further segmented as diagnostics, personalized medicines, drug discovery, and Research. This application is majorly used for diagnosis of cancer. Diagnostics holds the largest market share which is majorly attributed to the growing number of cancer patients worldwide.
研究institute is the largest segment as an end user for the market, and would hold dominating position during the forecast period. The growth of genomics market in cancer care is primarily driven by the need for accurate screening techniques that gives to the point diagnosis of cancer.
地理位置，北美在南北癌症市场的全球基因组学中占据了主导地位，其次是欧洲和亚太地区。北美的市场增长是由研究人员的精细研发基础设施的存在，大量患有癌症的患者，以及个人的高医疗保健支出。乐动娱乐官网虽然，亚太地区预计将拥有这些技术的渗透率增加，并提高生物野蛮行业的研发支出。乐动体育网址多少
在该行业中运营的领先公司包括安捷伦技术，罗氏诊断，贝克曼库尔特，Illumetrix，Cancer Genetic Inc.，Bio-rad Labs，Pacific Bio Science，Sigma Aldrich Corporation，GE Healthcare，Quect Diagnostics，Abbott乐动娱乐官网实验室，perkinelmer和luminex。
研究中的主要发现表明市场上可用的技术不断专注于将减少努力的技术进步，并提供准确诊断癌症。开发新技术的领先公司考虑了增加对使用这项技术的意识等因素，并达到未开发的市场。北美被认为将全球市场主导到预测岁月，亚太地区展示了印度蓬勃发展的经济体和中国的高增长迹象。
Polaris Market Research has segmented the genomics in cancer care market on the basis of product type, technology, application, end user and region:
Genomics in Cancer Care Product Type Outlook (Revenue, USD Million, 2015 – 2025)
- 消耗品
- Instruments
- Service
Genomics in Cancer Care Technology Type Outlook (Revenue, USD Million, 2015 – 2025)
- Gene Sequencing
- PCR
- 微阵列核酸提取和纯化
Genomics in Cancer Care Application Outlook (Revenue, USD Million, 2015 – 2025)
- 诊断
- 个性化药物
- 药物递送
- 研究
Genomics in Cancer Care Product End Use Outlook (Revenue, USD Million, 2015 – 2025)
- 医院
- 研究Institutes
- 一个cademic Research
Genomics in Cancer Care Product Regional Outlook (Revenue, USD Million, 2015 – 2025)
- 北美
- 我们。
- Canada
- Europe
- Germany
- 英国
- France
- Italy
- Spain
- 比利时
- 俄罗斯
- 荷兰
- Rest of Europe
- 一个sia-Pacific
- 中国
- India
- 日本
- Korea
- 新加坡
- Malaysia
- 印度尼西亚
- 泰国
- 菲律宾
- Rest of Asia-Pacific
- 拉美
- Brazil
- Mexico
- 阿根廷
- Rest of LATAM
- 中东和非洲
- 阿联酋
- Saudi Arabia
- 南非
- 剩下的MEA